Jing Ding1,
Wei Xu1,
Xiao-yan Cheng2,
Xi-hai Chen3,
Wen-jun Zhou4,
Rong Ma1,
Fan-ling Meng1
For correspondence:- Fan-ling Meng Email: dr_mfl1979@126.com Tel:+8613100938267
Accepted: 3 May 2023 Published: 30 May 2023
Citation: Ding J, Xu W, Cheng X, Chen X, Zhou W, Ma R, et al. Effectiveness of nab-paclitaxel versus traditional paclitaxels in the treatment of ovarian cancer. Trop J Pharm Res 2023; 22(5):1043-1050 doi: 10.4314/tjpr.v22i5.16
© 2023 The authors.
This is an Open Access article that uses a funding model which does not charge readers or their institutions for access and distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0) and the Budapest Open Access Initiative (http://www.budapestopenaccessinitiative.org/read), which permit unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited..
Archives
News Updates